Cadrenal Therapeutics, Inc. Common Stock (CVKD) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 2.86M | 4.32M | 4.08M | 5.97M | 7.94M | 10.11M | 4.67M | 5.44M | 7.03M | 8.49M | 9.28M | 3.52M | 4.44M | 727.6K | 541.36K |
| Cash & Short-Term Investments | 2.31M | 4.01M | 3.86M | 5.57M | 7.34M | 10.02M | 4.36M | 5.04M | 6.57M | 8.4M | 9.11M | 3.23M | 4.03M | 32.59K | 103.08K |
| Cash Only | 2.31M | 4.01M | 3.86M | 5.57M | 7.34M | 10.02M | 4.36M | 5.04M | 6.57M | 8.4M | 9.11M | 3.23M | 4.03M | 32.59K | 103.08K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 5.47K | 5.1K | 12.79K | 19.04K | 24.66K | 38.15K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 541.68K | 306.48K | 206.85K | 382.22K | 8.45K | 14.45K | 116.88K | 171.38K | 167.84K | 0 | 0 | 0 | 0 | 672.29K | 414.24K |
| Total Non-Current Assets | 6.79K | 7.34K | 7.9K | 6.44K | 8.47K | 10.74K | 6.8K | 13.67K | 20.4K | 27.08K | 33.57K | 39.89K | 42.79K | 50.58K | 3.97K |
| Property, Plant & Equipment | 4.62K | 5.17K | 5.73K | 4.28K | 4.68K | 6.94K | 3.01K | 9.88K | 16.61K | 23.29K | 29.78K | 36.1K | 39K | 44.59K | 1.77K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.17K | 2.17K | 2.17K | 2.17K | 3.79K | 3.79K | 3.79K | 3.79K | 3.79K | 3.79K | 3.79K | 3.79K | 3.79K | -526.01K | 2.19K |
| Total Assets | 2.86M | 4.33M | 4.09M | 5.98M | 7.95M | 10.12M | 4.68M | 5.46M | 7.05M | 8.52M | 9.31M | 3.56M | 4.48M | 778.17K | 545.32K |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -64.01% | -57.26% | -12.64% | 9.55% | 12.84% | 18.83% | -49.75% | 53.33% | 57.26% | 994.77% | 1607.54% | - | - | - | - |
| Total Current Liabilities | 1.06M | 1.59M | 1.35M | 1.68M | 1.84M | 2.68M | 1.27M | 1.46M | 856.32K | 826.88K | 563.57K | 374.31K | 401.63K | 1.33M | 672.36K |
| Accounts Payable | 824.81K | 650.66K | 614.13K | 895.61K | 1.28M | 1.5M | 496.82K | 759.52K | 400.37K | 167.32K | 141.66K | 78.14K | 119.57K | 404.9K | 308.22K |
| Days Payables Outstanding | 119.63K | - | 173.19K | - | 22.68K | - | - | - | - | - | - | 15.07K | - | 43.16K | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43.73K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 240.14K | 937.32K | 738.55K | 311.94K | 424.36K | 966.58K | 767.89K | 0 | 209.9K | 596.13K | 0 | 0 | 170.28K | 605.29K | 0 |
| Current Ratio | 2.68x | 2.72x | 3.02x | 3.56x | 4.32x | 3.77x | 3.69x | 3.72x | 8.21x | 10.27x | 16.46x | 9.40x | 11.05x | 0.55x | 0.81x |
| Quick Ratio | 2.68x | 2.72x | 3.02x | 3.56x | 4.32x | 3.77x | 3.69x | 3.72x | 8.21x | 10.27x | 16.46x | 9.40x | 11.05x | 0.55x | 0.81x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.23K | 8.8K | 15.17K | 4.99M | 1.05M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 553.34K | 528.47K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.23K | 8.8K | 15.17K | 21.35K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.42M | 524.31K |
| Total Liabilities | 1.06M | 1.59M | 1.35M | 1.68M | 1.84M | 2.68M | 1.27M | 1.46M | 856.32K | 826.88K | 565.8K | 383.1K | 416.8K | 6.33M | 1.73M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 2.23K | 8.8K | 15.17K | 21.35K | 27.22K | 32.86K | 38.33K | 640.71K | 528.47K |
| Net Debt | -2.31M | -4.01M | -3.86M | -5.57M | -7.34M | -10.02M | -4.36M | -5.03M | -6.55M | -8.38M | -9.08M | -3.2M | -3.99M | 608.12K | 425.39K |
| Debt / Equity | - | - | - | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | -301.53x | -88.88x | -31.05x |
| Total Equity | 1.8M | 2.74M | 2.73M | 4.3M | 6.11M | 7.44M | 3.41M | 3.99M | 6.19M | 7.69M | 8.75M | 3.18M | 4.07M | -5.55M | -1.18M |
| Equity Growth % | -70.6% | -63.19% | -19.85% | 7.68% | -1.28% | -3.29% | -60.98% | 25.7% | 52.32% | 238.57% | 841.28% | - | - | - | - |
| Book Value per Share | 0.75 | 1.37 | 1.34 | 2.19 | 3.31 | 4.88 | 3.09 | 3.74 | 5.79 | 8.86 | 10.07 | 4.06 | 5.20 | -7.16 | -0.10 |
| Total Shareholders' Equity | 1.8M | 2.74M | 2.73M | 4.3M | 6.11M | 7.44M | 3.41M | 3.99M | 6.19M | 7.69M | 8.75M | 3.18M | 4.07M | -5.55M | -1.18M |
| Common Stock | 2.51K | 2.34K | 2.06K | 2.01K | 1.91K | 1.78K | 1.23K | 16.01K | 16.01K | 13.02K | 13.02K | 11.72K | 11.72K | 8.19K | 8.13K |
| Retained Earnings | -41.46M | -38.96M | -35.92M | -33.24M | -29.57M | -25.72M | -21.54M | -19.13M | -16.73M | -15.07M | -13.93M | -12.89M | -11.89M | -6.71M | -1.7M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |